# LykonDX

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lykondx

- Industry: Medical Devices & Equipment
- Headquarters: Berlin, Germany
- Website: www.lykon.de
- Total disclosed funding: $9.7M
- Latest round: Series A (Sep 21, 2022)
- Investors on record: 4

## About

Founded in 2015 by Hans-Gert Stuke and Tobias Teuber, and based in Berlin, Germany, LykonDX GmbH operates as a provider of medical monitoring equipment. In June 2024, LifeSum AB, a portfolio company of Molten Ventures, NGP Capital, Balderton Capital, and SparkLabs Global Ventures, acquired LykonDX GmbH. The firm’s partners include Eurofins, Amedes, Imagene Labs, etc.

LYKON is a digital health company offering personalized nutrition solutions through home-based DNA and blood tests. Customers order tests online, collect samples at home, and send them to LYKON’s certified laboratories for analysis. Results and tailored recommendations are provided through a private profile, helping users achieve health goals such as improved digestion or weight management. LYKON’s products include dietary plans and health recommendations based on scientific research.

## Funding rounds

- Series A, Sep 21, 2022, $9.7M — Redstone, Ippen Digital GmbH & Co. KG, Zintinus, MA Ventures

## Investors

- Redstone (https://capitalatlas.ai/funds/redstone) — Series A
- Ippen Digital GmbH & Co. KG — Series A
- Zintinus (https://capitalatlas.ai/funds/zintinus) — Series A
- MA Ventures (https://capitalatlas.ai/funds/ma-ventures) — Series A